Advanced search×

The effects of growth hormone deficiency and growth hormone replacement therapy on intellectual ability, personality and adjustment in children.

Pediatr Endocrinol Rev 7(4):328-38 (2010) PMID 20684123

Traditionally, it has been assumed that intellectual development in children with growth hormone deficiency (GHD) is distributed between ranges of a normal population based on the observation that it does not differ substantially from that of children of the same age. Nevertheless, few studies have investigated this assumption. This Spanish Collaborative study was prospectively planned with two main purposes: to study a possible influence of GHD on intelligence quotient (IQ), personality traits and adaptative capacity and to study the evolution of these parameters during substitution therapy with growth hormone (GH). Although the overall intellectual ability of children with GHD is comparable to that of a normal reference population, some areas such the motor-component scale (evaluated by McCarthy test) and performance IQ (evaluated by WISC-R) were below the mean at the beginning of the study, showing significant improvement during therapy. Emotional adjustment (normal at study start) also improved significantly during treatment. Females showed better adjustment capacity before and during GH therapy. Longer studies with an increased number of cases are needed to confirm these effects of GHD and its treatment in children.

Version: za2963e q8za9 q8zbd q8zc0 q8zd7 q8ze9 q8zf0 q8zgb

Similar articles you may find interesting…

  1. Uterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2.

    Endocrinology 152(6):2474-82 (2011) PMID 21467199 PMCID PMC3100621

    We created a null allele of Cav1 mice by deleting its second exon through embryonic stem cell targeting. Immunohistochemical analysis demonstrated that CAV1 expression was primarily localized to endothelial blood vessel cells and the myometrium uterus, whereas the strongest expression of Rxfp2 was d...
  2. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.

    Am J Transplant 11(5):947-57 (2011) PMID 21521467